The human immunodeficiency virus (HIV) is no longer a death sentence, yet a cure remains elusive. While current therapies can successfully manage active infection, the virus can survive in tissue reservoirs – including macrophage cells, which play an important role in the immune system.
For the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV. A multidisciplinary team from Johns Hopkins Medicine completed the living donor HIV-to-HIV kidney transplant on Mar. 25. The doctors say both the donor and the recipient are doing well.
Privacy concerns linked to both health facilities and providers are major barriers to increasing the number of men who are tested and treated for HIV in Cote d’Ivoire, suggests new Johns Hopkins Center for Communication Programs (CCP) research. CCP is based at the Johns Hopkins Bloomberg School of Public Health.
Teens and young adults who were exposed to HIV and antiretroviral therapy before birth but are HIV-negative themselves are at increased risk of obesity and asthma-like symptoms, according to research to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.
There have been significant advances in clinical and scientific research in the understanding of blood-borne pathogens (BBPs), which are pathogenic microorganisms that are present in human blood and can cause disease in humans. These pathogens include, but are not limited to, hepatitis C virus (HCV), hepatitis D virus (HDV) and human immunodeficiency virus (HIV). Updating a statement from 1995, this document is intended as a general guide to clinical practice based on the current state of evidence, while acknowledging the need for modification as new knowledge becomes available.
A new study, published this month in Lancet HIV by Penn Medicine researchers, shows that a naltrexone implant placed under the skin was more effective at helping HIV-positive patients with an opioid addiction reduce relapse and have better HIV-related outcomes compared to the oral drug.
Shield Diagnostics, an Andreessen Horowitz-backed clinical laboratory tackling antibiotic resistance by bringing precision medicine to infectious disease, announced the launch of Target-NG, a rapid molecular test for antibiotic susceptibility in Neisseria gonorrhoeae.
The National Institute of Allergy and Infectious Diseases awarded a grant to researchers at New York University College of Dentistry to study HIV latency. The grant provides nearly $2 million over five years to support research led by David N. Levy, PhD, associate professor of basic science and craniofacial biology at NYU Dentistry.
The 2019 Pittsburgh Women who Rock Award will be presented to Sharon L. Hillier, Ph.D., at the 3rd annual Women who Rock Benefit Concert Presented by UPMC Health Plan and UPMC Magee-Womens Hospital on Thursday, May 30, at Stage AE. Dr. Hillier is professor and vice chair of the department of obstetrics
Johns Hopkins Medicine researchers are attending the annual Conference on Retroviruses and Opportunistic Infections (CROI), where they are sharing their latest findings in the ongoing battle against HIV/AIDS and related infectious diseases with other top basic, translational and clinical researchers from around the world. This year’s conference is being held March 4 to 7 at the Washington State Convention Center in Seattle.
Most heroin users in Baltimore, a city heavily affected by the opioid epidemic, recognize that the heroin they buy is now almost always laced with the highly dangerous synthetic opioid fentanyl, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Novel study to investigate how sexual trauma increases HIV susceptibility in women.
A new study reveals details about the evolutionary contest between HIV and the human immune system that could one day improve treatment. Research led by Shan-Lu Liu of The Ohio State University demonstrates the important role of one protein in allowing HIV to flourish within human cells despite the immune system’s efforts to beat it back.
Rutgers School of Public Health dean, Perry N. Halkitis and associate professor of epidemiology, Henry F. Raymond, have joined New Jersey’s new “End AIDS Epidemic Committee.” The Committee, which was convened by Governor Phil Murphy, is one of several measures being taken by New Jersey to curtail new HIV infections and improve the health of those living with the virus.
Researchers examined the effect of vaginal tenofovir 1 percent gel use on the risk of acquiring herpes simplex virus type 2, or HSV-2.
LeVar Burton, a celebrated American actor, director, producer and writer for more than 40 years, is adding another accolade—this one for his tireless, decades-long dedication to children’s literacy and AIDS research and treatment.
A new way to create proteins that can sneak through HIV’s protective coating may be a step toward understanding the key components needed for developing a vaccine for the virus, according to researchers.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right